[1]方邦江 齐文升 杨志旭 叶勇 李旭成7 周爽8 刘力.《新型冠状病毒肺炎诊疗方案(试行第九版)》中医治疗更新及其对奥密克戎变异株感染防治指导作用[J].陕西中医药大学学报,2022,(03):001-4.[doi:10.13424/j.cnki.jsctcm.2022.03.001]
 FANG Bangjiang QI Wensheng YANG Zhixu YE Yong LI Xucheng7 ZHOU Shuang8 LIU Li.Updated TCM Treatment in Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 9th Edition) and Its Guidance on Preventing and Treating SARS-CoV-2 Omicron Variant Infection[J].Journal of Shaanxi University of Traditional Chinese Medicine,2022,(03):001-4.[doi:10.13424/j.cnki.jsctcm.2022.03.001]
点击复制

《新型冠状病毒肺炎诊疗方案(试行第九版)》中医治疗更新及其对奥密克戎变异株感染防治指导作用
分享到:

《陕西中医药大学学报》[ISSN:2096-1340/CN:61-1501/R]

卷:
期数:
2022年03期
页码:
001-4
栏目:
疫病防治
出版日期:
2022-05-26

文章信息/Info

Title:
Updated TCM Treatment in Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 9th Edition) and Its Guidance on Preventing and Treating SARS-CoV-2 Omicron Variant Infection
文章编号:
2096-1340(2022)03-0001-04
作者:
方邦江123 齐文升4 杨志旭5 叶勇6 李旭成7 周爽8 刘力3
1.上海中医药大学附属龙华医院,上海 200032;
2.上海中医药大学急危重症研究所,上海 200032;
3.陕西中医药大学疫病研究院,陕西 西安 712046;
4.中国中医科学院广安门医院,北京 100000;
5.中国中医科学院西苑医院,北京 100091;
6.云南省中医院,云南 昆明 650500;
7.湖北省武汉市中医院,湖北 武汉 430000;
8.上海中医药大学针灸推拿学院,上海 201203
Author(s):
FANG Bangjiang123 QI Wensheng4 YANG Zhixu5 YE Yong6 LI Xucheng7 ZHOU Shuang8 LIU Li3
关键词:
关键词:新冠肺炎奥密克戎变异株中医药预防与治疗
Keywords:
Key words: COVID-19Omicron variantTCMPrevention and treatment
分类号:
R254.3
DOI:
10.13424/j.cnki.jsctcm.2022.03.001
文献标志码:
A
摘要:
摘 要:新冠肺炎奥密克戎变异株自首次发现及传播以来,在世界100多个国家流行,严重危害人类的生命健康。中医药防治新冠肺炎疗效确凿、优势显著。为了更加有效指导奥密克戎变异株感染临床防治,世界中医药学会联合会急症专业委员会、中国上海中医药大学急危重症研究所、陕西中医药大学疫病研究院组织国内《新型冠状病毒肺炎诊疗方案(试行第九版)》修订专家和临床防控一线救治专家,在《新型冠状病毒诊疗方案(试行第九版)》基础上,结合新型冠状病毒奥密克戎变异株感染防治临床经验,就新型冠状病毒奥密克戎变异株感染中医药防治相关问题展开调研与讨论,形成本专家建议,以期对当下新冠肺炎奥密克戎变异株感染临床治疗与预防起到指导作用。
Abstract:
Abstract: Since its first discovery,the SARS-CoV-2 Omicron variant (B.1.1.529) has been prevalent in more than 100 countries around the world,seriously endangering human life and health.Traditional Chinese medicine (TCM) has shown characteristic advantages in preventing and treating COVID-19 patients with definite curative effect.In order to guide the prevention and treatment of the SARS-CoV-2 Omicron variant infection more effectively,the Emergency Professional Committee of the World Federation of Chinese Medicine Societies,the Institute of Emergency and Critical Care Medicine of Shanghai University of Traditional Chinese Medicine,and the Research Institute of Pestilence of Shaanxi University of Chinese Medicine,organized the experts who participated the revision of the Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 9th Edition) and the doctors working on the frontline of prevention and control of COVID-19 to form the recommendations through investigation and discussion on the topic of preventing and treating the SARS-CoV-2 Omicron variant infection with TCM based on the Diagnosis and Treatment Protocol for COVID-19 Patients (Tentative 9th Edition) and clinical experience.It is hope that this recommendation can provide a guidance to the prevention and treatment of the current SARS-CoV-2 Omicron variant infection.

参考文献/References:

[1]国家卫生健康委,国家中医药管理局.新型冠状病毒肺炎诊疗方案(试行第九版)[EB/OL].(2022-03-12)[2022-03-14].http//www.nhc.gov.cn/yzygj/s7653p/202001/4294563 ed35b43209b31739bd 0785e67.shtml.
[2]郑芳萍,李娜芬,李晨瑶,等.基于真实世界研究厦门本土183例新型冠状病毒Delta变异株感染患者的临床特征及中医体质分布规律[J].中医药通报,2022,21(2):41-45.
[3]原丹,郑泽宇,庄森,等.2021年福建莆田新冠Delta株感染患儿中医证候及诊治规律初探[J].福建中医药,2021,52(10):1-2,5.
[4]张忠德,邹旭,林琳,等.广东省107例新型冠状病毒Delta变异株肺炎患者的中医证候特征及救治策略[J].中医杂志,2021,62(23):2073-2076.
[5]刘禹翔,李燕君,徐慕娟,等.援鄂深圳中医医疗队在雷神山医院治疗新冠肺炎经验总结[J].实用中医内科杂志,2021,35(1):83-85.
[6]孙培林.针灸在新型冠状病毒肺炎治疗中的应用[J].中医药导报,2020,26(10):12-17,41.
[7]戈佳磊,缪吉,徐婉仪,等.“培土生金”法在儿童新冠肺炎恢复期中医康复的临床应用[J].中国民族民间医药,2021,30(23):95-99.
[8]明阳灿,徐辉甫,徐婉仪,等.儿童新型冠状病毒肺炎的中医临床特征及辨证论治探索[J].时珍国医国药,2020,31(6):1447-1450.
[9]Zhou S,Feng J,Xie Q,et al.Traditional Chinese medicine shenhuang granule in patients with severe/critical COVID-19:A randomized controlled multicenter trial[J].Phytomedicine.2021,(89):153612.
[10]Wang Y,Liu Y,Lv Q,et al.Effect and safety of Chinese herbal medicine granules in patients with severe coronavirus disease 2019 in Wuhan,China:a retrospective,single-center study with propensity score matching[J].Phytomedicine,2021,(85):153404.
[11]刘维.境外输入新型冠状病毒奥密克戎变异株感染患者的中医证候特征[J].天津中医药,2022,39(2):142-146.
[12]Lin H,Wang X,Liu M,et al.Exploring the treatment of COVID-19 with Yinqiao powder based on network pharmacology[J].Phytother Res,2021:1-14.
[13]肖琦,蒋茵婕,吴思思,等.中药疏风解毒胶囊联合阿比多尔治疗轻症新型冠状病毒肺炎的价值分析[J].中国中医急症,2020,29(5):756-758.
[14]王蕾,张瑞明,赵艳玲,等.一清双解胶囊和片剂治疗急性上呼吸道感染风温病热在肺卫证的多中心随机对照双盲双模拟Ⅱ期临床试验[J].中西医结合学报,2008,6(2):139-147.
[15]孙仕奇,陈飞飞,尹成伟,等.六神丸联合常规治疗对COVID-19患者的临床疗效[J].中成药,2021,43(8):2277-2280.
[16]许洪波,刘妍如,周瑞,等.基于分子对接和网络药理学技术预测银翘解毒合剂防治新型冠状病毒肺炎的可行性[J].中国现代中药,2020,22(4):512-521,563.
[17]Deng W,Xu Y,Kong Q,et al.Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo[J].Signal transduction and targeted therapy,2020,5(1):66.
[18]方邦江,齐文升,黄烨.新型冠状病毒感染的肺炎中西医结合防控手册[M].北京:人民卫生出版社,2020:63-65.
[19]方邦江,张文,周爽,等.基于“急性虚证”理论防治新型冠状病毒肺炎探析[J].中医杂志,2021,62(9):826-828.
[20]方邦江,李灿辉,陈业孟,等.中医疫病学实践和理论的发展创新——中外专家谈新型冠状病毒肺炎中医治疗启示[J].中国中西医结合杂志,2020,40(11):1285-1290.
[21]包兆含,张文,邬鑫鑫,等.“截断扭转-扶正固本”法治疗疫病思想对新型冠状病毒肺炎救治的启示[J].中国中医急症,2020,29(8):1320-1322.
[22]阎博华,蒋志伟,曾洁萍,等.藿香正气口服液与金蒿解热颗粒联合使用对社区人群预防性干预COVID-19的大样本前瞻性临床研究[J].中国中药杂志,2020,45(13):2993-3000.

相似文献/References:

[1]李东方 李艳 陈音 崔杰 张敬锋 孟捷.基于数据挖掘的中医药治疗新型冠状病毒肺炎组方用药规律探析[J].陕西中医药大学学报,2022,(03):005.[doi:10.13424/j.cnki.jsctcm.2022.03.002]
 LI Dongfang LI Yan CHEN Yin CUI Jie ZHANG Jingfeng MENG Jie.Analysis on Prescription and Medication Rule of Traditional Chinese Medicine for Treatment of COVID-19 Based on Data Mining[J].Journal of Shaanxi University of Traditional Chinese Medicine,2022,(03):005.[doi:10.13424/j.cnki.jsctcm.2022.03.002]

备注/Memo

备注/Memo:
基金项目:国家重点研发计划项目(2018YFC1705900);国家中医紧急医学救援基地建设项目[ZY(2021-2023)-0101-01]
更新日期/Last Update: 2022-05-30